Mangrove Partners Buys AerCap Holdings NV, Spartan Energy Acquisition Corp, Stemline Therapeutics Inc, Sells PennyMac Financial Services Inc, PennyMac Financial Services Inc, Churchill Capital Corp

• New Purchases: AER, SPAQ, STML, CFFA, AMCI, FTAC, MNLO, CRSAU, MNCL, TRNE.U, CCH, SXC, RMG.U, ACAMU, DPHCU, WRLS, VEAC, GMHIU,
• Added Positions: CAI, CPRX, SMTA, CTRA, FLY, PVAC, GNK, ZFGN, METC, VRTS,
• Reduced Positions: AT,
• Sold Out: 1AC, 1AC, CCC.U, ALDX,

For the details of MANGROVE PARTNERS's stock buys and sells, go to https://www.gurufocus.com/guru/mangrove+partners/current-portfolio/portfolio

1. PDC Energy Inc (PDCE) - 2,022,717 shares, 11.96% of the total portfolio.
2. Penn Virginia Corp (PVAC) - 1,729,382 shares, 11.08% of the total portfolio. Shares added by 1.83%
3. EchoStar Corp (SATS) - 1,534,909 shares, 8.13% of the total portfolio.
4. Bonanza Creek Energy Inc (BCEI) - 2,021,700 shares, 6.67% of the total portfolio.
5. ANI Pharmaceuticals Inc (ANIP) - 549,401 shares, 5.63% of the total portfolio.

Mangrove Partners initiated holding in AerCap Holdings NV. The purchase prices were between $38.71 and $48.29, with an estimated average price of $45.13. The stock is now traded at around $50.36. The impact to a portfolio due to this purchase was 1.74%. The holding were 258,000 shares as of .

Mangrove Partners initiated holding in Spartan Energy Acquisition Corp. The purchase prices were between $9.63 and $9.83, with an estimated average price of $9.75. The stock is now traded at around $9.88. The impact to a portfolio due to this purchase was 1.29%. The holding were 900,000 shares as of .

Mangrove Partners initiated holding in Stemline Therapeutics Inc. The purchase prices were between $9.08 and $13.62, with an estimated average price of $11.27. The stock is now traded at around $15.12. The impact to a portfolio due to this purchase was 1.19%. The holding were 636,513 shares as of .

Mangrove Partners initiated holding in CF Finance Acquisition Corp. The purchase prices were between $9.75 and $9.95, with an estimated average price of $9.85. The stock is now traded at around $9.98. The impact to a portfolio due to this purchase was 1.01%. The holding were 700,000 shares as of .

Mangrove Partners initiated holding in AMCI Acquisition Corp. The purchase prices were between $9.68 and $10, with an estimated average price of $9.78. The stock is now traded at around $9.80. The impact to a portfolio due to this purchase was 1%. The holding were 700,000 shares as of .

Mangrove Partners initiated holding in FinTech Acquisition Corp III. The purchase prices were between $9.64 and $10.2, with an estimated average price of $9.71. The stock is now traded at around $9.75. The impact to a portfolio due to this purchase was 0.71%. The holding were 500,000 shares as of .

Mangrove Partners added to a holding in CAI International Inc by 35.34%. The purchase prices were between $21.63 and $26.57, with an estimated average price of $24.03. The stock is now traded at around $24.23. The impact to a portfolio due to this purchase was 0.86%. The holding were 976,559 shares as of .

Mangrove Partners added to a holding in Catalyst Pharmaceuticals Inc by 45.97%. The purchase prices were between $1.92 and $5.33, with an estimated average price of $2.92. The stock is now traded at around $3.89. The impact to a portfolio due to this purchase was 0.81%. The holding were 3,457,041 shares as of .

Mangrove Partners added to a holding in Contura Energy Inc by 22.23%. The purchase prices were between $54.94 and $65.98, with an estimated average price of $61.42. The stock is now traded at around $56.76. The impact to a portfolio due to this purchase was 0.28%. The holding were 184,382 shares as of .

Mangrove Partners added to a holding in Zafgen Inc by 63.95%. The purchase prices were between $2.63 and $5.3, with an estimated average price of $4.29. The stock is now traded at around $2.61. The impact to a portfolio due to this purchase was 0.19%. The holding were 1,209,324 shares as of .

Mangrove Partners added to a holding in Ramaco Resources Inc by 25.46%. The purchase prices were between $4.63 and $6.52, with an estimated average price of $5.62. The stock is now traded at around $6.50. The impact to a portfolio due to this purchase was 0.13%. The holding were 744,904 shares as of .

Mangrove Partners sold out a holding in PennyMac Financial Services Inc. The sale prices were between $17.62 and $21.4, with an estimated average price of $18.96.

Mangrove Partners sold out a holding in PennyMac Financial Services Inc. The sale prices were between $17.62 and $21.4, with an estimated average price of $18.96.

Mangrove Partners sold out a holding in Churchill Capital Corp. The sale prices were between $9.99 and $15.3, with an estimated average price of $12.1.

Mangrove Partners sold out a holding in Aldeyra Therapeutics Inc. The sale prices were between $7.14 and $9.85, with an estimated average price of $8.49.